Manulife (Manufacturers Life Insurance)
KYTX icon

Manulife (Manufacturers Life Insurance)’s Kyverna Therapeutics KYTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Hold
134,530
– – ﹤0.01% 1755
2025
Q4 		$1.26M Buy
134,530
+30,722
+30% +$228K ﹤0.01% 1743
2025
Q3 		$623K Sell
103,808
-14,489
-12% -$57.9K ﹤0.01% 2101
2025
Q2 		$363K Buy
118,297
+79,695
+206% +$197K ﹤0.01% 2302
2025
Q1 		$74.5K Buy
38,602
+808
+2% +$2.39K ﹤0.01% 2760
2024
Q4 		$141K Hold
37,794
– – ﹤0.01% 2742
2024
Q3 		$185K Hold
37,794
– – ﹤0.01% 2698
2024
Q2 		$283K Buy
37,794
+9,300
+33% +$142K ﹤0.01% 2445
2024
Q1 		$708K Buy
+28,494
New +$795K ﹤0.01% 2046

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s KYTX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) held its Kyverna Therapeutics (KYTX) position steady in Q1 2026 at 134,530 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

Manulife (Manufacturers Life Insurance) first reported a position in KYTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.26M in Q4 2025. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 134,530 shares of Kyverna Therapeutics worth $1.16M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) left its Kyverna Therapeutics share count unchanged in Q1 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1755 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Kyverna Therapeutics position peaked at $1.26M in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.